EGFL6 predicts unfavorable prognosis and serves as a potential indicator in esophageal carcinoma
Huijuan Jiang, Junling Zhu, Zhang Lei, Tuxunayi Yimamu, Xinhong Zhang, Aishanjiang Muhetaer, Hailin Chen, Amanjiang Aierken, Ainiwaerjiang Abudourousuli · 2026
Read EGFL6 predicts unfavorable prognosis and serves as a potential indicator in esophageal carcinoma by Huijuan Jiang, Junling Zhu, Zhang Lei, Tuxunayi Yimamu, Xinhong Zhang, Aishanjiang Muhetaer, Hailin Chen, Amanjiang Aierken, Ainiwaerjiang Abudourousuli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13457832.txt.
Description
Huijuan Jiang and colleagues examined a gene called EGFL6 in esophageal carcinoma, a cancer of the food pipe, to see whether it tracks with patient outcomes. Their 2026 study mined public cancer databases, including The Cancer Genome Atlas, hunting for basement-membrane genes switched on abnormally in these tumors. EGFL6, already known as a cancer-promoting gene in other tumor types, emerged as strongly overexpressed in esophageal tumors.
Higher EGFL6 levels were tied to shorter disease-specific survival and shorter time before the cancer progressed again in patient records. The analysis connected the gene with immune cell patterns inside tumors and with methylation changes on its DNA. Lab work completed the picture: esophageal cancer cells with active EGFL6 proliferated and invaded more aggressively and moved through the cell cycle faster. That supports the gene as a prognostic marker and possible drug target.
Catalog record
| CREATOR | Huijuan Jiang, Junling Zhu, Zhang Lei, Tuxunayi Yimamu, Xinhong Zhang, Aishanjiang Muhetaer, Hailin Chen, Amanjiang Aierken, Ainiwaerjiang Abudourousuli |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |